These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 19861397
21. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction. Aronow WS. Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919 [Abstract] [Full Text] [Related]
22. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [Abstract] [Full Text] [Related]
23. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. J Am Coll Cardiol; 2005 Dec 20; 46(12):2311-21. PubMed ID: 16360064 [Abstract] [Full Text] [Related]
24. Economic analysis of a randomized trial of biventricular pacing in Canada. Bentkover JD, Dorian P, Thibault B, Gardner M. Pacing Clin Electrophysiol; 2007 Jan 20; 30(1):38-43. PubMed ID: 17241313 [Abstract] [Full Text] [Related]
30. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP. J Cardiovasc Electrophysiol; 2006 May 20; 17(5):486-90. PubMed ID: 16684019 [Abstract] [Full Text] [Related]
31. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator. Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY. Europace; 2009 Jan 20; 11(1):80-5. PubMed ID: 18952828 [Abstract] [Full Text] [Related]
33. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Eur J Heart Fail; 2009 Dec 20; 11(12):1143-51. PubMed ID: 19884129 [Abstract] [Full Text] [Related]
38. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, Ghali J, Barnet JH, Feldman AM, Bristow MR. J Am Coll Cardiol; 2005 Dec 20; 46(12):2329-34. PubMed ID: 16360067 [Abstract] [Full Text] [Related]